Publications scientifiques sur les diagnostics non invasifs BioPredictive

Études évaluées par les pairs validant les diagnostics sanguins BioPredictive pour les maladies du foie — des cohortes pionnières aux méta-analyses à long terme.

39/435 Publications

  1. Noninvasive Assessment of Liver Fibrosis. Key publication Review

    Castera L et al. · N Engl J Med · 2025

    FibroTest Metabolic

  2. The non-invasive assessment of hepatic fibrosis. Review

    Gheorghe G et al. · J Formos Med Assoc · 2021

    ActiTest FibroTest Alcohol HBV +2

  3. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Review

    Moreno C et al. · J Hepatol · 2019

    FibroTest Alcohol

  4. Glycogenic hepatopathy. Review

    Khoury J et al. · Hepatobiliary Pancreat Dis Int · 2018

    FibroTest Metabolic

  5. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. Review

    Vilar-Gomez E et al. · J Hepatol · 2018

    FibroTest Metabolic

  6. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Review

    Parikh P et al. · Ann Transl Med · 2017

    FibroTest HBV

  7. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. Review

    Bril F et al. · Diabetes Care · 2017

    FibroTest Metabolic

  8. Acoustic Radiation Force Impulse Imaging for Diagnosis and Monitoring of Liver Fibrosis in Patients with Hepatitis C: A Review of Diagnostic Accuracy, Clinical Effectiveness, Cost-Effectiveness, and Guidelines Review

    · 2016

    FibroTest HCV

  9. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Review

    Golabi P et al. · Expert Rev Gastroenterol Hepatol · 2016

    FibroTest Metabolic

  10. Management of the patient with SVR. Review

    Terrault NA et al. · J Hepatol · 2016

    FibroTest HCV

  11. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. Review

    Stasi C et al. · World J Gastroenterol · 2016

    FibroTest HCV

  12. Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. Review

    Matta B et al. · Curr HIV/AIDS Rep · 2016

    FibroTest HBV HCV HIV

  13. Current Possibilities to Assess the Degree of Liver Fibrosis in Patients with Haemophilia Infected with HCV--Review. Review

    Kucharska M et al. · Adv Clin Exp Med · 2015

    FibroTest HCV

  14. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. Review

    Lombardi R et al. · World J Gastroenterol · 2015

    FibroTest Alcohol

  15. Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Review

    Wong GL et al. · Clin Mol Hepatol · 2015

    FibroTest Alcohol HBV HCV +1

  16. Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis. Review

    Brener S · Ont Health Technol Assess Ser · 2015

    Elasto-FibroTest FibroTest Alcohol HBV +3

  17. [SWE elastography in assessment of liver fibrosis]. Review

    Zaleska-Dorobisz U et al. · Postepy Hig Med Dosw (Online) · 2015

    FibroTest HBV HCV

  18. Hepatitis B: are non-invasive markers of liver fibrosis reliable? Review

    Castera L · Liver Int · 2014

    FibroTest HBV HCV

  19. Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters? Review

    Gentile I et al. · Infez Med · 2014

    FibroTest HCV

  20. Liver fibrosis markers in alcoholic liver disease. Review

    Chrostek L et al. · World J Gastroenterol · 2014

    FibroTest Alcohol

  21. Non-invasive diagnosis of hepatitis B virus-related cirrhosis. Review

    Lee S et al. · World J Gastroenterol · 2014

    FibroTest HBV

  22. [Biomarkers for liver fibrosis: advances, advantages and disadvantages]. Review

    Cequera A et al. · Rev Gastroenterol Mex · 2014

    FibroTest HCV

  23. [Prognosis assessment of alcoholic liver disease: how and why?]. Review

    Trabut JB et al. · Presse Med · 2014

    FibroTest Alcohol

  24. [The value of noninvasive serological markers in hepatitis B]. Review

    García-Samaniego J et al. · Gastroenterol Hepatol · 2014

    FibroTest HBV

  25. Noninvasive evaluation of NAFLD. Review

    Castera L et al. · Nat Rev Gastroenterol Hepatol · 2013

    ActiTest FibroTest NashTest SteatoTest +1

  26. Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. Review

    Festi D et al. · Aliment Pharmacol Ther · 2013

    SteatoTest

  27. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. Review

    Afdhal NH et al. · J Viral Hepat · 2013

    ActiTest FibroTest HCV

  28. Non-invasive evaluation of liver fibrosis in chronic hepatitis C. Review

    Trifan A et al. · Rev Med Chir Soc Med Nat Iasi · 2012

    FibroTest HCV

  29. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Review

    Ahmad W et al. · Virol J · 2011

    FibroTest HCV

  30. Non-invasive markers for hepatic fibrosis. Review

    Baranova A et al. · BMC Gastroenterol · 2011

    FibroTest Alcohol HBV HCV +3

  31. Noninvasive assessment of portal hypertension in patients with cirrhosis. Review

    Thabut D et al. · Hepatology · 2011

    FibroTest Alcohol HBV HCV +3

  32. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary. Review

    · Prescrire Int · 2010

    FibroTest HCV

  33. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Review

    Boursier J et al. · Eur J Gastroenterol Hepatol · 2009

    FibroTest HCV

  34. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. Review

    Castera L · J Viral Hepat · 2009

    FibroTest HBV HCV HIV

  35. Biomarkers of liver fibrosis. Review

    Poynard T et al. · Adv Clin Chem · 2008

    ActiTest FibroTest SteatoTest Alcohol +5

  36. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Key publication Review

    Poynard T et al. · Gastroenterol Clin Biol · 2008

    ActiTest FibroTest SteatoTest Alcohol +5

  37. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience. Key publication Review

    Munteanu M et al. · J Gastrointestin Liver Dis · 2008

    ActiTest AshTest FibroTest NashTest +6

  38. FibroMAX: towards a new universal biomarker of liver disease? Review

    Morra R et al. · Expert Rev Mol Diagn · 2007

    ActiTest AshTest FibroTest NashTest +7

  39. Poynard T, Imbert-Bismut F, Ratziu V Review

    ActiTest FibroTest HBV HCV

Affichage de la liste complète des résultats. La page est rendue côté serveur et non paginée.